The ACCC has flagged competition concerns about drug supplier Sigma Healthcare’s proposed $8.8 billion reverse merger with Chemist Warehouse, saying the tie-up could harm independent pharmacies and lessen competition in pharmacy retail.
After an 18-month investigation, the Office of the Australian Information Commissioner has lodged civil penalty proceedings against Medibank over its October 2022 data breach, accusing the health insurer of breaching the Privacy Act.
Drug giant Pfizer has blasted Samsung Bioepis’ “fishing expedition” in its suit alleging infringement of the patent for its blockbuster arthritis drug Enbrel, telling the court the Korean biotech should not be allowed to dig for new grounds of invalidity.
A judge has upheld Neurim Pharmaceutical’s claim for additional damages against two generic drug companies found to have infringed its patent for insomnia drug Circadin, despite the company’s failure to comply with an earlier ruling.
Otsuka Pharmaceutical has hit back at suit filed by Indian generics company Sun Pharma seeking to invalidate its patent for blockbuster antipsychotic Abilify, filing a cross-claim seeking to restrain Sun Pharma from infringing the patent with a generic version of the drug.
Drug giant Glaxo has succeeded in extending the term for a patent for a drug that treats chronic obstructive pulmonary disease and asthma, with a delegate rejecting arguments from law firm Banki Haddock Fiora that the application was incorrectly based on a patent that was no longer valid because of amendments.
Medicinal cannabis company Vitura Health has won its bid for orders restricting the access of a software partner to its IT systems after an alleged hack.
South Korean biotech ToolGen has won court approval to patent its genome editing technology CRISPR, after an earlier bid to protect its IP found the revolutionary technology was not patentable.
Ramsay Health Care has won a partial interim injunction banning the union representing its nurses from running ads that claim the private hospital operator runs on a staff-to-patient ratio double that of public hospitals.
Medibank CEO David Koczkar has taken the stand to help defeat a class action’s bid to uncover several reports, including three by Deloitte, commissioned in the wake of a massive data breach, which the health insurer argues are privileged.